大庆华科(000985) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥539,811,195.48, representing a year-on-year increase of 12.31%[3] - The net profit attributable to shareholders for Q3 2021 was ¥8,559,582.73, a decrease of 50.05% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥6,932,638.49, down 57.97% year-on-year[3] - The basic earnings per share for Q3 2021 was ¥0.07, a decline of 50.08% compared to the same period last year[3] - Operating profit for the current period was ¥16,380,921.66, compared to ¥13,800,031.44 in the previous period, indicating a growth of 18.7%[9] - Net profit decreased to ¥13,047,610.87 from ¥13,767,428.14, representing a decline of 5.2% year-over-year[19] - The company reported a total comprehensive income of ¥13,047,610.87, down from ¥13,767,428.14, indicating a decline of 5.2%[19] - The basic and diluted earnings per share were both ¥0.101, down from ¥0.106 in the previous period[19] Assets and Liabilities - The total assets at the end of Q3 2021 amounted to ¥769,089,948.35, reflecting a 10.72% increase from the end of the previous year[4] - As of September 30, 2021, the company's total assets amounted to CNY 769,089,948.35, an increase from CNY 694,655,529.43 at the end of 2020[15] - The company's total liabilities as of September 30, 2021, were CNY 176,989,702.06, compared to CNY 116,453,469.16 at the end of 2020, indicating a significant increase in liabilities[16] - The company's total equity attributable to shareholders at the end of Q3 2021 was ¥592,100,246.29, a 2.40% increase from the previous year[4] - The company's total equity as of September 30, 2021, was CNY 592,100,246.29, compared to CNY 578,202,060.27 at the end of 2020, showing a growth in shareholder equity[16] - The company reported a significant increase in contract liabilities, which rose to CNY 41,405,195.66 from CNY 15,531,511.07 year-over-year[16] - The company’s non-current liabilities decreased slightly to CNY 50,776,653.40 from CNY 54,097,674.10, indicating a reduction in long-term obligations[16] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥133,418,346.74, an increase of 17.08%[3] - Cash flow from operating activities generated a net amount of ¥133,418,346.74, an increase from ¥113,954,678.24 in the previous period[22] - The company's cash and cash equivalents increased to CNY 340,206,551.85 as of September 30, 2021, up from CNY 219,880,931.48 at the end of 2020, reflecting improved liquidity[14] - Cash and cash equivalents at the end of the period totaled ¥340,206,551.85, up from ¥302,180,961.42, marking an increase of 12.6%[23] Expenses - Total operating costs amounted to ¥1,523,485,605.05, up from ¥1,332,553,108.56, reflecting a year-over-year increase of 14.3%[9] - Research and development expenses were ¥5,983,615.14, slightly down from ¥6,125,998.01, reflecting a decrease of 2.3%[9] - Sales expenses decreased significantly to ¥5,028,156.92 from ¥10,392,450.16, a reduction of 51.6%[9] Corporate Actions - The company completed the internal decision-making process for the transfer of state-owned shares, with 20,339,700 shares (15.69% of total shares) being transferred from Lin Yuan Refinery to Daqing Petrochemical on August 16, 2021[10] - The company announced the resignation of Chairman Ma Tiegang on July 9, 2021, which may impact future strategic direction[9]